Tongli Pharmaceuticals (USA), Inc. Watch

from 10-K 2 pages Supplemental Agreement

from 10-K 2 pages Agreement of Termination of the Contract

from 10-K 1 page Tongli Pharmaceutical (USA), Inc Independent Director’s Complementary Agreement Company: Director: Tongli Pharmaceutical (USA), Inc By: Name: Mingli Yao Hui Shao Title: Chief Executive Officer

from 10-K 5 pages Material contract

from 10-K 1 page Supplementary Agreement

from 10-K ~1 page Land Use Right Transfer Agreement

from 10-K 2 pages Material contract

from 10-K 4 pages Material contract

from 10-K 1 page Patent Assignment Termination Agreement

from 10-K ~1 page Patent Assignment Agreement

from 10-K 2 pages Class II New Drug Approval Assignment Agreement

from 8-K 6 pages Independent Director’s Agreement

from 8-K 3 pages Independent Director Contract

from 8-K 2 pages Independent Director’s Contract This Agreement (The “Agreement”) Is Entered Into, as of June 1, 2008, by and Between American Tony Pharmaceutical, Inc. a New York Corporation (Hereinafter Referred to as the “Company”), and Jack L. Kaye, Independent Director (Hereinafter Referred to as the “Director”). Background the Company Desires to Retain the Director for the Duties of Independent Director and Chairman of the Audit Committee. the Director Desires to Be Retained for Such Positions. Agreement in Consideration for the Above Recited Promises and the Mutual Promises Contained Herein, the Adequacy and Sufficiency of Which Are Hereby Acknowledged, the Company and the Director Hereby Agree as Follows

from 8-K 4 pages Independent Director’s Contract

from 8-K 12 pages Merger Agreement by and Among Aim Smart Corporation, Atp Acquisition Corp. and American Tony Pharmaceutical, Inc. Dated as of July 22, 2008 Merger Agreement